Tranexam, 500 mg 10 pcs

Antifibrinolytic agent.

Tranexamic acid specifically inhibits profibrinolysin (plasminogen) activation and its conversion into fibrinolysin (plasmin).

It has local and systemic hemostatic action during bleeding associated with increased fibrinolysis (platelet pathology, menorrhagia).

Also tranexamic acid has anti-allergic and anti-inflammatory effect due to suppression of kinins and other active peptides involved in allergic and inflammatory reactions.

Indications

Active ingredient

Composition

How to take, the dosage

Ingestion, regardless of meals.

Short-term treatment of bleeding due to increased fibrinolysis: The recommended standard dose of tranexamic acid is 15-25 mg/kg body weight, averaging 1000-1500 mg 2-3 times daily.

The use of the drug in special groups of patients

Kidney function disorders

In patients with mild to moderate impaired renal excretory function, adjustment of the dose and frequency of tranexamic acid is necessary:

Interaction

When used in combination with hemostatic drugs and hemocoagulase, it is possible to activate thrombosis.

Special Instructions

Synopsis

Features

Contraindications

Side effects

Overdose

There are no data on overdose of the drug.

Pregnancy use

Similarities